Ultragenyx Pharmaceutical Inc. (RARE) Dividend History

Company News

• Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference

  Ultragenyx Pharmaceutical Inc. announced that its CEO, Emil Kakkis, M.D., Ph.D., will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025.

  GlobeNewswire Inc.
• Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update

  Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on rare and ultra-rare genetic diseases, will host a conference call on May 6, 2025, to discuss its Q1 2025 financial results and provide a corporate update.

  GlobeNewswire Inc.
• Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  Ultragenyx Pharmaceutical Inc. granted 36,831 restricted stock units to 21 newly hired non-executive officers as an inducement to join the company. The awards vest over four years and were approved by the compensation committee.

  GlobeNewswire Inc.
• 2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies

  The report provides a comprehensive analysis of the Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline, highlighting the potential of this technology to revolutionize the treatment of genetic disorders. It examines the challenges in scalable production and safety, as well as the industry's focus on optimizing vectors for improved safety, specificity, and efficiency.

  GlobeNewswire Inc.

  Featured Companies: ADVM BIIB FDMT JNJ MGTX PASG RCKT RGNX SRPT TNYA
• Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight

  The cell and gene therapies in rare disorders market is expected to grow significantly by 2034, driven by an increase in approvals and adoption of these treatments, ability to treat a broad array of conditions, and rising prevalence of rare disorders.

  GlobeNewswire Inc.

  Featured Companies: ABEO BCLI CAPR EDIT FDMT FOLD OCGN PFE RGNX SGMO